FTC Charges Ephedra Product Marketers

Share this article:
The Federal Trade Commission yesterday unveiled charges against companies accused of deception in marketing products containing the substance ephedra.


In its complaints, the FTC charged that the companies made false claims that products containing ephedra caused rapid and permanent weight loss without side effects or health risks and that clinical studies supported those claims.


The sweep resulted in two settlements and one pending complaint.


Health Laboratories of North America Inc. and USA Pharmacal Sales Inc. agreed to cease making the claims and to pay a total of $370,000 to compensate consumers, the FTC said.


The FTC is still pursuing complaints against Michael S. Levey and Gary Ballen, both California residents, and their companies on the same charges.


Levey and Ballen advertised their products through brochures, the FTC said. Health Laboratories and USA Pharmacal relied on direct mail and regional newspaper advertising.


Ephedra is a dietary supplement available over the counter. However, U.S. health experts have warned against its use, and the substance has come under scrutiny after the deaths of several athletes, including Major League Baseball pitcher Steve Belcher, who used ephedra.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in News

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

Customer Centricity Is Spurring Marketing-Tech Investments

Customer Centricity Is Spurring Marketing-Tech Investments

A majority of marketers rank customer satisfaction improvements as paramount in the technology investment decisions.

Big, Bold Moves in the C-Suite

Big, Bold Moves in the C-Suite ...

JCPenney appoints Home Depot's Marvin Ellison as CEO; Harte Hanks and JWT add hitting power to their C-level benches

Campaign Comes to the States

Campaign Comes to the States

DMN's UK-based sister publication launches Campaign US